Truvada
- Product NDC
- 70518-0097
- 11-digit product format
- 705180097
- Labeler code
- 70518
- Product ID
- 70518-0097_df38be31-b767-7143-e053-2995a90a05c6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- emtricitabine and tenofovir disoproxil fumarate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA021752
- Marketing category
- NDA
- Marketing start
- 2016-12-30
- Marketing end
- 0000-00-00
- Substance
- EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- Active strength
- 200 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0097-0 | 70518009700 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0097-0) | 2016-12-30 | 0000-00-00 | No | No | Current |
| 70518-0097-1 | 70518009701 | 3 TABLET, FILM COATED in 1 BLISTER PACK (70518-0097-1) | 2017-02-22 | 0000-00-00 | No | No | Current |